Anixa Biosciences, Inc. (ANIX) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)
A side-by-side comparison of Anixa Biosciences, Inc. and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIX
Anixa Biosciences, Inc.
$3.01HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
PLYX
Polaryx Therapeutics, Inc. Common Stock
$2.10HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
Total return — ANIX vs PLYX
growth of $100 · dividends reinvested · last 1yANIX +0.3% (+0.3%/yr)PLYX -94.1% (-94.1%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
ANIX PLYX
ANIX vs PLYX: by the numbers
- •PLYX is the larger company ($105M vs $102M market cap).
Metrics side by side
Valuation
| Metric | ANIX | PLYX |
|---|---|---|
| P/B ratio | 7.08 | 9.57 |
Profitability
| Metric | ANIX | PLYX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -72.02% | -62.61% |
| ROIC | -82.35% | -47.75% |
Growth (annualized)
| Metric | ANIX | PLYX |
|---|---|---|
| Total return CAGR (5Y) | -8.26% | N/A |
Go deeper
Dig into the metrics
Anixa Biosciences ROEPolaryx Therapeutics, Inc. Common Stock ROEAnixa Biosciences operating marginPolaryx Therapeutics, Inc. Common Stock operating marginAnixa Biosciences revenue growthPolaryx Therapeutics, Inc. Common Stock revenue growthAnixa Biosciences free cash flowPolaryx Therapeutics, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.